If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Medical Affairs » Field Medical Excellence
Download FREE Excerpt
15 Info Graphics
40 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Biotech; Pharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Health Care; Chemical
Amgen; Astellas; AstraZeneca; Bayer; Daiichi Sankyo; Eisai; EMD Serono; Genentech; GlaxoSmithKline ; Ipsen; Janssen; Merck; Merck KGaA; Roche; Shire
Best Practices, LLC engaged 20 medical affairs and field-based medical team leaders from 15 leading oncology biopharma companies through a benchmarking survey. Six deep-dive interviews were conducted with medical affairs leaders, whose insights were provided to enrich the data and add real-world context to the metrics and trends established.
To provide clear understanding of field medical trends across major markets, benchmark data is segmented by: Total Benchmark Class (N=20); Global Market Segment, excluding U.S. (N=11); North America Market Segment (N=9); and Europe (EU5) Market Segment (N=4).
Key topics covered in this report include: